AKT1 and neoplasm: Inhibition of AKT, a key downstream node of diverse receptor tyrosine kinases, G-protein-coupled receptors, and cytokine receptors, shows great promise for suppressing angiogenesis, halting tumor growth and overcoming drug resistance [18].